
MD candidate at @harvardmed @mit_hst | @ragon_institute Immunology PhD ‘24 | @Caltech BioE '18 | dancing, sunrise hikes, vegan cooking, biking 🏔 💃 🥼 she/her
Cambridge, MA
Joined March 2018
- Tweets60
- Following578
- Followers300
- Likes3.9K
Anusha Nathan, PhD retweeted
Congrats to my PhD advisor @CarolynBertozzi for winning the @NobelPrize!
In addition to your brilliant science, you are a role model and inspiration to many young queer scientists, including some of the current ones in your lab (pictured)! #NobelPride
Anusha Nathan, PhD retweeted
Belonging, in healthcare and society at large, starts with a name. I'm grateful to @SuzanneKovenMD & colleagues @MGHSurgery for helping me pen my reflections in this essay. I hope many of you across #MedTwitter will relate & reflect #OurNamesBelong : cmaj.ca/content/194/22/E777
Anusha Nathan, PhD retweeted
Story in @BostonGlobe today highlighting @ragoninstitute physician-scientist @GaihaGaurav. We need universal COVID vaccines! Scientists say we need universal coronavirus vaccines, but will they arrive in time? bostonglobe.com/2022/03/10/b… via @BostonGlobe
Anusha Nathan, PhD retweeted
Primordium is now offering everyone the chance to sample our full-plasmid sequencing service for FREE - never use Sanger sequencing again! Please retweet this message and we'll DM you a coupon to sequence 5 ENTIRE PLASMIDS 100% FREE, no CC or PO needed. primordiumlabs.com 5/
Anusha Nathan, PhD retweeted
There are a few results:
1. Omicron still uses ACE2
2. There is a very large drop in neutralization of Omicron by BNT162b2 immunity relative to ancestral virus
3. Omicron escape from BNT162b2 neutralization is incomplete. Previous infection + vaccination still neutralizes
Anusha Nathan, PhD retweeted
We have completed our first experiments on neutralization of Omicron by Pfizer BNT162b2 vaccination elicited immunity
Manuscript available at
sigallab.net/
and should be available on medRxiv in the coming days
Anusha Nathan, PhD retweeted
Today with @emblebi, we're launching the #AlphaFold Protein Structure Database, which offers the most complete and accurate picture of the human proteome, doubling humanity’s accumulated knowledge of high-accuracy human protein structures - for free: dpmd.ai/alphafolddb 1/
Anusha Nathan, PhD retweeted
Just published @CellCellPress
Another step towards a pancoronavirus vaccine, T-cell based, using structural biology, and providing advantages (stronger CD8+ T cell) over current mRNA approaches
cell.com/cell/fulltext/S0092… @ragoninstitute @GaihaGaurav @anushamnathan @mit_hst
Anusha Nathan, PhD retweeted
Happy Birthday to the most expeditiously executed vaccine product Phase 1 clinical trial start in history!!! And, good morning especially to Dr. Jackson, folks at the NIAID trials network, and the bold and giving volunteers who made it all possible. 💉 ♥️
Our (co-inventors @McLellan_Lab) COVID-19 vaccine (spike delivered by @moderna_tx's mRNA) was just injected into the 1st human in phase 1 trial, only 66 days after viral sequence release... a testament to rapid vaccine development for emerging diseases🦠💚
niaid.nih.gov/news-events/ni…
Anusha Nathan, PhD retweeted
What a journey has this project been for all of us, it’s humbling to see it get here. Immensely grateful to the amazing volunteers, to @BIDMC_CVVRTrial, to @JNJNews and to our entire team. Our hearts are so full to be able to witness this moment that we worked so hard for. – at Boston, MA
Today, FDA issued an emergency use authorization (EUA) for the third vaccine for the prevention of #COVID19 caused by SARS-CoV-2. The EUA allows the vaccine to be distributed in the U.S for use in individuals 18 years and older. fda.gov/news-events/press-an…


















